PT-141 10 mg
Batch: PSPT10-1
Janoshik Test Report · September 9, 2026
Reported amounts: 11.67 mg; 11.72 mg; 11.64 mg
Reported purity: 99.875%; 99.849%; 99.891%
Client name redacted
OPEN REPORTP3 Documentation Center
Find a document.
Search available analytical records by peptide name or report date. Each document remains identified by its applicable batch or lot.
01 · SearchEnter a peptide name or report date.
02 · SelectOpen the matching analytical document.
03 · ReviewConfirm the product, date, and document details.
6 documents available. Search by peptide, date, strength, or lot.
AVAILABLE DOCUMENTS
MOTS-C 10 mg
Batch: 2026082310
Analytical Test Report · October 12, 2026
Reported amount: 11.38 mg · Purity: 99.061%
Manufacturer and QR code redacted
OPEN REPORT
KLOW 80 · Batch 6380
Janoshik Test Report · Analysis July 28, 2026
Reported amounts: GHK-Cu 52.44 mg · TB-500 13.47 mg
BPC-157 11.23 mg · KPV 13.04 mg
Task #205735 · Manufacturer redacted
OPEN REPORT
Tirzepatide · Batch 308055
Janoshik Test Report · Analysis September 15, 2026
Reported amounts: 30.57 mg; 30.70 mg
Reported purity: 99.669%; 99.566%
Sample: Blind GLP-1 · Manufacturer redacted
OPEN REPORT
Tirzepatide 20 mg
Batch/Lot: G7 T20
Certificate of Analysis · Report issued September 8, 2026
Privacy-redacted copy · Page 1 only
OPEN REPORT
Retatrutide 10 mg
Batch: 2026-Reta10-3
Analytical Test Report · July 31, 2026
Privacy-redacted copy
OPEN REPORTFor help with a supplied lot, email support@p3peptides.co.
DOCUMENTATION POLICY: P3 does not treat a certificate or analytical record for one lot as evidence for another lot.